Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy

References

• World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Hepatitis B. WHO website. Available to: http://www.who.int/immunization_monitoring/diseases/hepatitis/en/index.html
   Google Scholar
• Romano’ L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis 2011; 43:Suppl 1 S2 - 7; http://dx.doi.org/10.1016/S1590-8658(10)60685-8; PMID: 21195368
   PubMedGoogle Scholar
• Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. [Review] Vaccine 2008; 26:6266 - 73; http://dx.doi.org/10.1016/j.vaccine.2008.09.056; PMID: 18848855
   PubMed Web of Science ®Google Scholar
• Law 27 May 1991, n. 165. Obbligatorietà della vaccinazione contro l'epatite virale B. Gazz. Uff. 1° giugno 1991, n. 127.
   Google Scholar
• Da Villa G, Sepe A. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. Vaccine 1999; 17:1734 - 8; http://dx.doi.org/10.1016/S0264-410X(98)00414-9; PMID: 10194831
   PubMed Web of Science ®Google Scholar
• Istituto Superiore di Sanità. Integrated Epidemiological System Of Acute Viral Hepatitis (Sistema Epidemiologico Integrato dell'Epatite Virale Acuta, SEIEVA). SEIEVA website. Available at: http://www.iss.it/seieva.
   Google Scholar
• Crovari P, Coppola RC, Icardi GC, Bonanni P. Efficacia e sicurezza dei vaccini contro l’epatite B. In: Fondazione SmithKline, editor. La vaccinazione contro l’epatite B: una scelta prioritaria di politica sanitaria ed economica. Milano, Franco Angeli Editore; 1990. p. 59–84.
   Google Scholar
• Dellamano R. Vaccinare contro l’epatite B: un costo senza ritorno o un buon investimento? In: Ghetti V, editor. La Vaccinazione di Massa contro l’Epatite B in Italia. Basi Fisio-patologiche, Epidemiologiche e Socio-economiche. Milano, Franco Angeli Editore; 1991. p. 31–76.
   Google Scholar
• Italian Ministry of Health. Hepatitis B vaccination coverage. Italian Ministry of Health website. Available to: http://www.salute.gov.it.
   Google Scholar
• Istituto Nazionale di Statistica (ISTAT)/National Institute of Statistics. Demografia in cifre. Population resident in Italy at the 1st January from 1991 to 2010, grouped by years and age range, divided by year and age. Demo.istat website. Available at: http://demo.istat.it.
   Google Scholar
• Fattovich G. Natural history of hepatitis B. J Hepatol 2003; 39:Suppl 1 S50 - 8; http://dx.doi.org/10.1016/S0168-8278(03)00139-9; PMID: 14708678
   PubMed Web of Science ®Google Scholar
• Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992 - 1000; http://dx.doi.org/10.1093/clinids/20.4.992; PMID: 7795104
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151:599 - 603; http://dx.doi.org/10.1093/infdis/151.4.599; PMID: 3973412
   PubMed Web of Science ®Google Scholar
• Lavarini C, Farci P, Chiaberge E, Veglio V, Giacobbi D, Bedarida G, et al. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis. Br Med J (Clin Res Ed) 1983; 287:1254 - 6; http://dx.doi.org/10.1136/bmj.287.6401.1254; PMID: 6416354
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001; 34:1225 - 41; http://dx.doi.org/10.1053/jhep.2001.29401; PMID: 11732013
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507 - 39; http://dx.doi.org/10.1002/hep.21513; PMID: 17256718
   PubMed Web of Science ®Google Scholar
• Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008; 48:335 - 52; http://dx.doi.org/10.1016/j.jhep.2007.11.011; PMID: 18096267
   PubMed Web of Science ®Google Scholar
• Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 2005; 37:622 - 7; http://dx.doi.org/10.1016/j.dld.2005.02.010; PMID: 15996630
   PubMedGoogle Scholar
• Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006; 43:Suppl 1 S173 - 81; http://dx.doi.org/10.1002/hep.20956; PMID: 16447285
   PubMed Web of Science ®Google Scholar
• McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49:Suppl S45 - 55; http://dx.doi.org/10.1002/hep.22898; PMID: 19399792
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB, Italian Hospitals’ Collaborating Group. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 2009; 81:1999 - 2006; http://dx.doi.org/10.1002/jmv.21643; PMID: 19856477
   PubMed Web of Science ®Google Scholar
• Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain. [Review] Eur J Gastroenterol Hepatol 2008; 20:320 - 6; http://dx.doi.org/10.1097/MEG.0b013e3282f340c8; PMID: 18334876
   PubMed Web of Science ®Google Scholar
• Colombo GL, Gaeta GB, Viganò M, Di Matteo S. A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy. Clinicoecon Outcomes Res 2011; 3:37 - 46; http://dx.doi.org/10.2147/CEOR.S16655; PMID: 21935331
   PubMedGoogle Scholar
• Cucchetti A, Cescon M, Trevisani F, Morelli MC, Ercolani G, Pellegrini S, et al. What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?. Dig Liver Dis 2012; 44:523 - 9; http://dx.doi.org/10.1016/j.dld.2012.01.018; PMID: 22387286
   PubMedGoogle Scholar
• Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V, et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997; 92:66 - 72; PMID: 8995940
   PubMed Web of Science ®Google Scholar
• de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103:1630 - 5; PMID: 1426884
   PubMed Web of Science ®Google Scholar
• Santi V, Buccione D, Di Micoli A, Fatti G, Frigerio M, Farinati F, et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J Hepatol 2012; 56:397 - 405; http://dx.doi.org/10.1016/j.jhep.2011.05.026; PMID: 21756850
   PubMed Web of Science ®Google Scholar
• Vitale A, Volk ML, Pastorelli D, Lonardi S, Farinati F, Burra P, et al. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology 2010; 51:165 - 73; http://dx.doi.org/10.1002/hep.23260; PMID: 19877181
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Pasquini P, Mele A. HBsAg carriers among pregnant women in Italy: results from the screening during a vaccination campaign against hepatitis B. Public Health 1988; 102:329 - 33; http://dx.doi.org/10.1016/S0033-3506(88)80102-1; PMID: 3217485
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Pasquini P, Mele A. A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. Vaccine 1989; 7:152 - 4; http://dx.doi.org/10.1016/0264-410X(89)90056-X; PMID: 2526420
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Pasquini P. Five years of vaccination campaign against hepatitis B in Italy in infants of hepatitis B surface antigen carrier mothers. Ital J Gastroenterol 1990; 22:195 - 7; PMID: 2131945
   PubMedGoogle Scholar
• Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2003; 21:1246 - 9; http://dx.doi.org/10.1016/S0264-410X(02)00439-5; PMID: 12559805
   PubMed Web of Science ®Google Scholar
• Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A, Collaborating Study Group. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect 2011; 62:165 - 71; http://dx.doi.org/10.1016/j.jinf.2010.11.014; PMID: 21129400
   PubMed Web of Science ®Google Scholar
• Filipponi F, Pisati R, Cavicchini G, Ulivieri MI, Ferrara R, Mosca F. Cost and outcome analysis and cost determinants of liver transplantation in a European National Health Service hospital. Transplantation 2003; 75:1731 - 6; http://dx.doi.org/10.1097/01.TP.0000063828.20960.35; PMID: 12777864
   PubMed Web of Science ®Google Scholar